OpenEvidence is the official AI medical knowledge platform in the United States, designed exclusively for healthcare professionals (doctors, nurses, pharmacists). The tool relies on content agreements signed with the world’s largest medical journals: NEJM, JAMA, NCCN, Cochrane, and dozens of others. Answers are anchored in peer-reviewed medical literature, with figures, tables, and treatment algorithms directly accessible. The application is free and unlimited for verified US healthcare professionals, available on iOS and Android.
What is OpenEvidence?
The essentials
OpenEvidence is a US medical AI platform designated as official partner of the New England Journal of Medicine, JAMA and JAMA Network, NCCN, and Cochrane. It is freely accessible to verified US healthcare professionals via web and mobile apps. The platform positions itself as the reference clinical AI for doctors, nurses, and pharmacists seeking rapid medical answers rooted in science.
Key features
OpenEvidence integrates full content — figures, tables, and algorithms — from partner journals. Professionals can ask clinical questions in natural language and receive structured answers with citations. NCCN treatment algorithms for oncology are directly accessible. A Visits Doctor Dialer module complements the offering. The application is available on iOS and Android for mobile use.
Use cases
OpenEvidence is used to quickly obtain evidence-based therapeutic recommendations, verify drug interactions, consult NCCN oncology algorithms, or prepare clinical presentations with the latest data. It is especially useful during ward rounds or urgent consultations requiring rapid clinical responses.
Advantages
The main benefit is trust: answers are anchored in peer-reviewed publications from world authorities. For a physician, this represents tremendous time savings versus traditional PubMed search, while guaranteeing source quality and currency. Complete free access for verified professionals eliminates any financial barrier to adoption.
Pricing
OpenEvidence is completely free and unlimited for verified US healthcare professionals. A verification procedure is required at registration. Access terms for non-US professionals are not publicly specified.
Conclusion
OpenEvidence is one of the rare AI tools to have successfully positioned itself in the highly regulated medical sector, by building editorial partnerships that give it unmatched scientific legitimacy. For US clinicians, it is a reference tool whose adoption is difficult to overlook.